{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:45:49Z","timestamp":1771998349841,"version":"3.50.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pemphigoid (Pg) diseases are a group of potentially fatal autoimmune mucocutaneous diseases. They have different clinical phenotypes, involving only the skin or multiple mucous membranes. They occur globally and frequently affect the elderly. The common marker among all variants is the presence of autoantibodies targeting the dermal-epidermal or mucosal-submucosal junctions, or basement membrane zone (BMZ). Four target antigens in the BMZ were studied. These included BPAG1, BPAG2 and subunits of \u03b16 and \u03b24 human integrins. Our objective was to find a molecular basis for the global incidence of Pg diseases and a mechanism that will explain the vast differences in clinical phenotypes and outcomes. All the variants of Pg that were analyzed had a statistically significant association with HLA-DQ\u03b21*03:01 in ten countries on four continents. This explains the reason for global incidence. Prediction models discovered multiple peptides in each of the four antigens that serve as T cell epitopes. These T cell epitopes were shown to bind to HLA-DQ\u03b21*03:01. In addition, structure modelling demonstrated the peptide-HLA complex bound to the T cell receptor. These autoreactive T cells would stimulate B cells to produce specific anti-BMZ autoantibodies. Anti-BMZ autoantibodies with different specificities will produce different phenotypes, which will account for involvement of different tissues and organs in different molecules. The contribution this study makes is that it provides a molecular basis of why a similar disease occurs in different racial groups. Furthermore, it provides the basis for the production of autoantibodies with different specificities, which resultantly produces different phenotypes.<\/jats:p>","DOI":"10.3389\/fimmu.2022.807173","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T04:50:11Z","timestamp":1642740611000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Molecular Basis for Global Incidence of Pemphigoid Diseases and Differences in Phenotypes"],"prefix":"10.3389","volume":"13","author":[{"given":"A. Razzaque","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro A.","family":"Reche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid Diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet Lond Engl"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03007-X","article-title":"Pemphigus and Bullous Pemphigoid","volume":"354","author":"Nousari","year":"1999","journal-title":"Lancet Lond Engl"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.01.029","article-title":"Infectious Complications in Bullous Pemphigoid: An Analysis of Risk Factors","volume":"72","author":"Phoon","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B4","first-page":"101","article-title":"Trends in Aging\u2013United States and Worldwide","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00220","article-title":"The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.370","article-title":"The First International Consensus on Mucous Membrane Pemphigoid: Definition, Diagnostic Criteria, Pathogenic Factors, Medical Treatment, and Prognostic Indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13023-018-0855-x","article-title":"Molecular Diagnosis of Anti-Laminin 332 (Epiligrin) Mucous Membrane Pemphigoid","volume":"13","author":"Chiorean","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02466","article-title":"Anti-P200 Pemphigoid: A Systematic Review","volume":"10","author":"Kridin","year":"2019","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0733-8635(03)00116-5","article-title":"Blistering Diseases in the Elderly: Diagnosis and Treatment","volume":"22","author":"Sami","year":"2004","journal-title":"Dermatol Clin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of Disease: Pemphigus and Bullous Pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"B11","unstructured":"Ocular Pemphigoid\n            SchonbergS\n            StokkermansTJ\n          Treasure Island (FL)StatPearls PublishingStatPearls"},{"key":"B12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial Pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2013.07.003","article-title":"Mucous Membrane Pemphigoid","volume":"57","author":"Xu","year":"2013","journal-title":"Dent Clin North Am"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4773","article-title":"Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane Pemphigoid","author":"Van Beek","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15251","article-title":"Role of BP230 Autoantibodies in Bullous Pemphigoid","volume":"47","author":"Shih","year":"2020","journal-title":"J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.08.031","article-title":"Autoantibodies to BPAG1e Trigger Experimental Bullous Pemphigoid in Mice","volume":"141","author":"Makita","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11404","article-title":"Identification of Epitopes Within Integrin \u03b24 for Binding of Auto-Antibodies in Ocular Cicatricial and Mucous Membrane Pemphigoid: Preliminary Report","volume":"54","author":"Rashid","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1968","article-title":"Identification of an Epitope Within Human Integrin Alpha 6 Subunit for the Binding of Autoantibody and its Role in Basement Membrane Separation in Oral Pemphigoid","volume":"176","author":"Rashid","year":"2006","journal-title":"J Immunol Baltim Md 1950"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.16.8569","article-title":"A Common Major Histocompatibility Complex Class II Allele HLA-DQB1* 0301 is Present in Clinical Variants of Pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.16.7747","article-title":"Common Major Histocompatibility Complex Class II Markers in Clinical Variants of Cicatricial Pemphigoid","volume":"91","author":"Yunis","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.24.11579","article-title":"Association of DQw7 (DQB1*0301) With Ocular Cicatricial Pemphigoid","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01238","article-title":"Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid","volume":"10","author":"Tasanen","year":"2019","journal-title":"Front Immunol"},{"key":"B24","article-title":"HLA-DRB1 and HLA-DQB1 Genes in Susceptibility and Resistance to Cicatricial Pemphigoid in French Caucasians","volume":"8","author":"Drouet","year":"1998","journal-title":"Eur J Dermatol EJD"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2174\/138161209789105162","article-title":"Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview","volume":"15","author":"Lafuente","year":"2009","journal-title":"Curr Pharm Des"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s0198-8859(02)00432-9","article-title":"Prediction of MHC Class I Binding Peptides Using Profile Motifs","volume":"63","author":"Reche","year":"2002","journal-title":"Hum Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-004-0709-7","article-title":"Enhancement to the RANKPEP Resource for the Prediction of Peptide Binding to MHC Molecules Using Profiles","volume":"56","author":"Reche","year":"2004","journal-title":"Immunogenetics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9433-5-1","article-title":"Elicitation From Virus-Naive Individuals of Cytotoxic T Lymphocytes Directed Against Conserved HIV-1 Epitopes","volume":"5","author":"Reche","year":"2006","journal-title":"Med Immunol Lond Engl"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-0366-5_1","article-title":"Protein Structure Modeling With MODELLER","volume":"1137","author":"Webb","year":"2014","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"B30","first-page":"1","article-title":"Association Between HLA-DQB1*03:01 and Bullous Pemphigoid in Iranian Patients","volume":"10","author":"Esmaili","year":"2013","journal-title":"Iran J Immunol IJI"},{"key":"B31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5021\/ad.2018.30.1.8","article-title":"HLA-C*17, DQB1*03:01, DQA1*01:03 and DQA1*05:05 Alleles Associated to Bullous Pemphigoid in Brazilian Population","volume":"30","author":"Chagury","year":"2018","journal-title":"Ann Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01037.x","article-title":"HLA-DR and DQ Polymorphisms in Bullous Pemphigoid From Northern China","volume":"27","author":"Gao","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.02.021","article-title":"The HLA-DQB1*03:01 Is Associated With Bullous Pemphigoid in the Han Chinese Population","volume":"138","author":"Sun","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.11.014","article-title":"Association of HLA Class I and Class II Alleles With Bullous Pemphigoid in Chinese Hans","volume":"89","author":"Fang","year":"2018","journal-title":"J\u00a0Dermatol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02350.x","article-title":"The Association of HLA-DQ7 With Bullous Pemphigoid is Restricted to Men","volume":"138","author":"Banfield","year":"1998","journal-title":"Br J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3335","article-title":"Identification and Characterization of Autoreactive T Cell Responses to Bullous Pemphigoid Antigen 2 in Patients and Healthy Controls","volume":"102","author":"B\u00fcdinger","year":"1998","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2000.tb02141.x","article-title":"Polymorphisms of HLA-DR and -DQ Genes in Japanese Patients With Bullous Pemphigoid","volume":"27","author":"Okazaki","year":"2000","journal-title":"J Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12332352","article-title":"Significantly Increased Occurrence of HLA-DQB1*0301 Allele in Patients With Ocular Cicatricial Pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13054","article-title":"A Service Evaluation of the Diagnostic Testing for Mucous Membrane Pemphigoid in a UK Oral Medicine Unit","volume":"49","author":"Walton","year":"2020","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04380.x","article-title":"Mucous Membrane Pemphigoid: HLA-DQB1*0301 Is Associated With All Clinical Sites of Involvement and may be Linked to Antibasement Membrane IgG Production","volume":"145","author":"Setterfield","year":"2001","journal-title":"Br J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0092-5","article-title":"HLA Alleles in British Caucasians With Mucous Membrane Pemphigoid","volume":"32","author":"H\u00fcbner","year":"2018","journal-title":"Eye Lond Engl"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04448.x","article-title":"HLA-DQB1 Alleles in Italian Patients With Mucous Membrane Pemphigoid Predominantly Affecting the Oral Cavity","volume":"145","author":"Carrozzo","year":"2001","journal-title":"Br J Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.11.023","article-title":"HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors","volume":"138","author":"Ujiie","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3166","article-title":"Gliptin-Associated Bullous Pemphigoid and the Expression of Dipeptidyl Peptidase-4\/CD26 in Bullous Pemphigoid","volume":"99","author":"Lindgren","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1101\/gr.083394.108","article-title":"Geographical Structure and Differential Natural Selection Among North European Populations","volume":"19","author":"McEvoy","year":"2009","journal-title":"Genome Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/1523-1747.ep12484029","article-title":"HLA DQB1*0301 Allele Is Involved in the Susceptibility to Erythema Multiforme","volume":"97","author":"Khalil","year":"1991","journal-title":"J Invest Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910590413","article-title":"HLA-DQB1*0301 Association With Increased Cutaneous Melanoma Risk","volume":"59","author":"Lee","year":"1994","journal-title":"Int J Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8690208","article-title":"Association of Gastric Adenocarcinoma With the HLA Class II Gene DQB10301","volume":"111","author":"Lee","year":"1996","journal-title":"Gastroenterology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1103","article-title":"Association Between High-Risk HPV Types, HLA DRB1* and DQB1* Alleles and Cervical Cancer in British Women","volume":"82","author":"Cuzick","year":"2000","journal-title":"Br J Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13660","article-title":"Bullous Pemphigoid and its Association With Neurological Diseases: A Systematic Review and Meta-Analysis","volume":"30","author":"Lai","year":"2016","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/tan.12960","article-title":"Hertl M. A Multi-Hit Hypothesis of Bullous Pemphigoid and Associated Neurological Disease: Is HLA-DQB1*03:01, a Potential Link Between Immune Privileged Antigen Exposure and Epitope Spreading","volume":"89","author":"Amber","year":"2017","journal-title":"HLA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2016.02.010","article-title":"Pemphigoid Gestationis: Toward a Better Understanding of the Etiopathogenesis","volume":"34","author":"Sadik","year":"2016","journal-title":"Clin Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1995.tb02668.x","article-title":"Class II MHC Typing in Pemphigoid Gestationis","volume":"20","author":"Shornick","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2003.01282.x","article-title":"Clinicopathological Features and HLA Tissue Typing in Pemphigoid Gestationis Patients in Kuwait","volume":"28","author":"Nanda","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-4362.1999.00524.x","article-title":"Class II Major Histocompatibility Complex Typing Across the Ethnic Barrier in Pemphigoid Gestationis. A Study in Mexicans","volume":"38","author":"Garc\u00eda-Gonz\u00e1lez","year":"1999","journal-title":"Int J Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.02.003","article-title":"Predicting Peptide Binding to Major Histocompatibility Complex Molecules","volume":"10","author":"Liao","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00153.x","article-title":"Epitopes Targeted by Bullous Pemphigoid T Lymphocytes and Autoantibodies Map to the Same Sites on the Bullous Pemphigoid 180 Ectodomain","volume":"115","author":"Lin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2004.08.003","article-title":"T Cell Receptor Gene Usage of BP180-Specific T Lymphocytes From Patients With Bullous Pemphigoid and Pemphigoid Gestationis","volume":"113","author":"Hacker-Foegen","year":"2004","journal-title":"Clin Immunol Orlando Fla"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The Global Burden of Rheumatoid Arthritis: Estimates From the Global Burden of Disease 2010 Study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.137","article-title":"The Global Burden of SLE: Prevalence, Health Disparities and Socioeconomic Impact","volume":"12","author":"Carter","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1144-9","article-title":"Systemic Sclerosis: A World Wide Global Analysis","volume":"28","author":"Coral-Alvarado","year":"2009","journal-title":"Clin Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1600-0609.2008.01206.x","article-title":"Immune Thrombocytopenic Purpura: Epidemiology and Implications for Patients","volume":"71","author":"Michel","year":"2009","journal-title":"Eur J Haematol Suppl"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol Clin"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The Pathogenesis of Rheumatoid Arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of Immune Thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.04.003","article-title":"Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis","volume":"43","author":"van Drongelen","year":"2017","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.807173\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T04:50:18Z","timestamp":1642740618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.807173\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2022.807173"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.807173","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"article-number":"807173"}}